|
Specialty Pharmacy Clinical Policy Bulletins
Aetna Non-Medicare Prescription Drug Plan
Subject: Specialty Quantity Limit Otezla 2271-H P2025
Policy: Program DescriptionThe standard limit is designed to allow a quantity sufficient for the most common uses of the medication. The recommended dosing parameters for all FDA-approved indications fall within the standard limits. Coverage of an additional quantity may be reviewed on a case-by-case basis upon request. Covered Quantities
FDA-recommended DosingPlaque Psoriasis (PsO), Psoriatic Arthritis (PsA), Behcet’s diseaseAdults (PsO, PsA, Behcet’s disease) and Pediatrics (6-17 years old) PsO weighing at least 50 kgDay 1 to day 5 dosage titration schedule:
Day 6 and thereafter: 30 mg in morning and 30 mg in evening Pediatrics (6-17 years old) PsO weighing 20 kg to less than 50 kgDay 1 to day 5 dosage titration schedule:
Day 6 and thereafter: 20 mg in morning and 20 mg in evening Place of Service: Outpatient The above policy is based on the following references:
June 07, 2025 |
|
Additional Information
|
|||||||||||||
| Company Information | Site Map | Aetna.com Home | Help | Contact Us | Search |
|
Web Privacy Statement | Legal Statement | Privacy Notices | Member Disclosure
|